CNXU Conexeu Sciences Inc.

Fundamentals / CIK 0002066836 / USD

Conexeu Sciences Inc. reported $7.16M in total assets through July 31, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNXU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for CNXU.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2025-07-31 2025-04-30
Research & Development $270K $67K $135K $42K
Total Operating Expenses $7.69M $2.38M $1.30M $457K
Operating Income -$7.69M -$2.38M -$1.30M -$457K
EBITDA -$7.68M -$2.37M -$1.29M -$454K
Interest Income $34K $84K $386 $0
Interest Expense $0 $0 -$43 $1.4K
Income Before Tax -$7.73M -$2.30M -$1.30M -$458K
Income Tax Expense $0 $0 $0 $0
Net Income -$7.73M -$2.30M -$1.30M -$458K
Basic EPS -$0.29 -$0.11 -$0.09 -$0.05
Diluted EPS -$0.29 -$0.11 -$0.09 -$0.05
Basic Shares Outstanding 27.0M 20.6M 14.1M 9.5M
Diluted Shares Outstanding 27.0M 20.6M 14.1M 9.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for CNXU.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2025-10-31
Cash & Cash Equivalents $1.97M $6.85M $4.81M
Cash & Short-Term Investments $1.97M $6.85M $4.81M
Total Current Assets $6.76M $7.91M $7.46M
Property, Plant & Equipment, Net $74K $38K $11K
Intangible Assets $164K $164K $177K
Total Non-Current Assets $400K $286K $230K
Total Assets $7.16M $8.20M $7.69M
Total Current Liabilities $1.27M -- $336K
Total Non-Current Liabilities $33K -- $0
Total Liabilities $1.31M $1.00M $336K
Total Debt (incl. Leases) $72K -- --
Common Stock $27K $21K $19K
Retained Earnings -$16.27M -$8.54M -$4.52M
Total Stockholders' Equity $5.85M $7.20M $7.35M
Total Equity $5.85M $7.20M $7.35M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for CNXU.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2025-07-31 2025-04-30
Net Income -$7.73M -$2.30M -$1.30M -$458K
Depreciation & Amortization $5.4K $11K $6.6K $3.4K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for CNXU.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2025-07-31 2025-04-30
Current Ratio 5.31x -- -- --
Quick Ratio 1.55x -- -- --
Debt to Equity 0.01x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002066836) · from April 30, 2025 Data through July 31, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal